MINNEAPOLIS--(BUSINESS WIRE)--June 16, 2006--Medtronic Inc., (NYSE:MDT - News) commends the recent national payment policy decision by the United States Centers for Medicare and Medicaid Services (CMS) for implantable cardiac device evaluations using remote monitoring technology. This decision simplifies physician billing for remote monitoring technologies that benefit thousands of cardiac patients across the U.S. Remote device monitoring systems, such as the Medtronic CareLink® Network, provide information that may allow physicians to monitor their patients and make important treatment decisions without the need for an office visit.
